ZARA, Gian Paolo
 Distribuzione geografica
Continente #
NA - Nord America 5.170
EU - Europa 2.992
AS - Asia 1.882
AF - Africa 56
SA - Sud America 29
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 9
Totale 10.158
Nazione #
US - Stati Uniti d'America 5.080
CN - Cina 893
IT - Italia 547
IE - Irlanda 441
SE - Svezia 403
SG - Singapore 380
UA - Ucraina 305
DE - Germania 292
FI - Finlandia 254
FR - Francia 241
KR - Corea 213
GB - Regno Unito 140
AT - Austria 133
IN - India 117
PL - Polonia 107
VN - Vietnam 84
CA - Canada 79
BE - Belgio 35
SN - Senegal 35
RU - Federazione Russa 31
ID - Indonesia 30
JP - Giappone 30
IR - Iran 29
TR - Turchia 25
BR - Brasile 21
AU - Australia 18
PK - Pakistan 18
NL - Olanda 17
TH - Thailandia 13
HK - Hong Kong 11
MX - Messico 11
ES - Italia 9
BY - Bielorussia 8
CH - Svizzera 8
JO - Giordania 8
MU - Mauritius 8
EU - Europa 7
UZ - Uzbekistan 6
DK - Danimarca 5
EG - Egitto 5
IL - Israele 5
IQ - Iraq 5
TW - Taiwan 5
PT - Portogallo 4
ZA - Sudafrica 4
RO - Romania 3
AP - ???statistics.table.value.countryCode.AP??? 2
AR - Argentina 2
CL - Cile 2
CZ - Repubblica Ceca 2
GR - Grecia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RS - Serbia 2
TN - Tunisia 2
UY - Uruguay 2
BT - Bhutan 1
CO - Colombia 1
EE - Estonia 1
GE - Georgia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
ZW - Zimbabwe 1
Totale 10.158
Città #
Chandler 705
Beijing 619
Dublin 441
Santa Clara 378
Singapore 302
Ashburn 265
Jacksonville 253
Fairfield 243
Torino 243
Ann Arbor 242
Houston 214
Woodbridge 147
Medford 144
Nyköping 142
Villeurbanne 135
Vienna 131
Wilmington 129
Princeton 127
Columbus 112
Dearborn 110
Warsaw 106
Seattle 91
Pisa 77
Cambridge 70
Fremont 55
Milan 55
Dong Ket 52
Washington 45
Redwood City 41
Boston 39
Boardman 37
Toronto 37
Verona 33
Shanghai 32
Brussels 31
Nanjing 29
Jakarta 25
Pune 25
Guangzhou 24
Falls Church 20
Ottawa 20
Norwalk 19
Hefei 14
New York 14
Los Angeles 13
Bangkok 11
Helsinki 11
Zhengzhou 11
Hyderabad 10
Monmouth Junction 10
Mumbai 10
Hong Kong 9
Kunming 9
Lachine 9
Wuhan 9
Chengdu 8
Jinan 8
Melbourne 8
Mountain View 8
Phoenix 8
Shenyang 8
Fuzhou 7
Hangzhou 7
Kansas City 7
San Diego 7
Chongqing 6
Coimbatore 6
Detroit 6
Islamabad 6
Karachi 6
Saint Petersburg 6
Smithtown 6
São Paulo 6
Auburn Hills 5
Chicago 5
Montréal 5
Munich 5
Nuremberg 5
Yuseong-gu 5
Ankara 4
Changsha 4
Groningen 4
London 4
Novosibirsk 4
Nürnberg 4
Tappahannock 4
Tianjin 4
Xian 4
Zurich 4
Ardabil 3
Berlin 3
Catania 3
Davis 3
Düsseldorf 3
Edinburgh 3
Genova 3
Gent 3
Hanoi 3
Hillsborough 3
Kalyan 3
Totale 6.412
Nome #
Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits 343
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses 334
Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG 311
Solid lipid nanoparticles and microemulsions for drug delivery The CNS. 257
Drug Delivery Nanoparticles in Skin Cancers 232
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. 208
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells. 196
5-Fluorouracile loaded beta-ctclodextrin nanosponges: in vitro characterisation and cytotoxicity 190
High energy shock waves and 5-aminolevulinic for sonodynamic therapy: effects in a syngeneic model of colon cancer 184
Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines 135
Solid lipid nanoparticles for brain tumors therapy: State of the art and novel challenges 133
Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line 130
Innovative formulations for the controlled and site-specific delivery of antiinflammatory drugs 124
Baclofen-loaded solid lipid nanoparticles: Preparation, electrophysiological assessment of efficacy, pharmacokinetic and tissue distribution in rats after intraperitoneal administration 120
Determination of disodium clodronate in human plasma and urine using gas-chromatography-nitrogen-phosphorous detection: validation and application in pharmacokinetic study 118
Application of pharmacoeconomics to the use of antibiotics. 115
Antibiotic dosage individualization through Bayesian inference on PK-PD population data 114
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion and migration of colon cancer cells 111
Insulin-Loaded SLN Prepared with the Emulsion Dilution Technique: In Vivo Tracking of Nanoparticles after Oral Administration to Rats 111
Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients 110
Solid lipid nanoparticles as anti-inflammatory drug delivery system in a human inflammatory bowel disease whole blood model 110
Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN). 108
Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I--a pharmacokinetic study. 106
Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distribution. 106
Solid lipid nanoparticles formed by solvent-in-water emulsion diffusion tecnique: development and influence of insulin stability 105
High Energy Shock Waves (HESW) for Sonodynamic Therapy: Effects on HT-29 Human Colon Cancer Cells 105
Accumulation and cytotoxic activity of different doxorubicin formulations in human cancer cell lines 102
Plasma Erythropoietin levels in patients receiving intensive platinum or non-platinum chemotherapy 101
Azione citotossica in vitro del colesterilbutirrato incorporato in nanoparticelle lipidiche solide 100
A new apomorphine formulation for oral administration 99
Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. 95
Different approaches in SLN formulation for cancer therapy 94
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells 94
A Non-Parametric Population PK/PD Analysis Of Tolcapone To Predict L-Dopa Plasma Concentrations 93
Analysis of thiopurine-methyl-transferase (TPMT) genotype and phenotype in a northern Italian population 92
Cytotoxicity of solid lipid nanoparticles incorporating butyric acid and doxorubicin on a human colorectal cancer cell line 91
Analgesic effect of bisphosphonates in mice. 89
HPLC determination of 5-FU and three metabolites in the plasma of cancer patients 89
Challangers and Opportunities of Nanoparticle-Based Theranostics in Skin Cancer 88
SLN per la veicolazione di un analogo fluorescente della Ciclosporina A 87
Application of Parzaen-based probabilistic neural networks to predict individual plasma concentration from population data 86
5-Aminolevulinic Acid and High Energy Shock Waves for Sonodynamic Therapy: Effects on SK-N-BE and SH-SY5Y Neuroblastoma Cell Lines 86
Enhanced oral bioavailability of resveratrol using lipid formulations 84
Ophthalmic delivery of dexamethasone and tobramycin incorporated in solid lipid nanoparticles 84
Oral bioavailability of Silymarin phytocomplex formulated as self-emulsifying pellets 83
Simultaneous HPLC determination of 5-Fluorouracil and its metabolites in plasma of cancer patients 82
Aminosalycilates do not affect thiopurine-methyl-transferase (TPMT) activity in inflammatory bowel disease (IBD) 82
5-Aminolevulinic Acid and High Energy Shock Waves for Sonodynamic Therapy: effects on SK-N-BE and SH-SY5Y neuroblastoma cell lines 82
Validation of a non-parametric approach to predict individual plasma concentrations from population data 82
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells 81
Thiopurine-methyl-transferase (TPMT) activity in inflammatory bowel disease (IBD) patients is not affected by co-administration of salycilates 81
Thiopurine S-methyltransferase pharmacogenetics on a large-scale healthy Italian caucasian population: difference in enzyme activity 81
Motilin and erythromycin do not affect the motility of rat duodenum in vivo 81
Plasma immunoerythropoietin levels in patients with cancer receiving platin-based or 5-Fluorouracil-based chemotherapy 80
Economic impact of resistance in the community. 79
Atypical chest pain: coronary or esophageal disease? 79
Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines 79
Pharmacokinetics of cyclosporine in recipients of marginal versus standard liver transplants 77
Single dose intramuscolar pharmacokinetics and local tolerability of three different disodium clodronate formulations in healthy volunteers 76
Individualization of Ceftriaxone dosage through Bayesian inference on PK/PD population data 75
Methotrexate loaded SLN prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetic and biodistribution 75
Accumulation and cytotoxic activity of different doxorubicin formulations in human cancer cell lines 74
GSH-responsive nanoparticles in the treatment of tumor cells. 74
Impact of age in phenothype of thiopurine methyltransferase 72
[Anamnestic study of thoracic pain: comparison of angina and gastroesophageal reflux] 71
Solid Lipid Nanoparticles carrying oligonucleotides inhibit Vascular Endothelial Grow Factor expression in rat glioma models 71
Prescriptive styles of general practitioner identified through Bayesian autoclassification method 71
Espression of CYP3A Isoforms and P-Glycoprotein in Human Stomach, Jejunum and Ileum 71
Analgesic, Anti-inflammatory and gastric-damaging effects of dexibuptofen in rodents. 70
Study of thiopurine-methyl-transferase (TPMT) genotype and phenotype in an Italian population 70
Plasma concentrations of 5-Fluorouracil and its metabolites in colon cancer patients 70
Evaluation of antiproliferative activity of cholesteryl butyrate solid lipid nanospheres on leukemic cell lines 69
Differences between Italian children and adults in thiopurine methyltransferase phenotype and genotype 69
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells 68
Dexibuprofen (S(+)-isomer Ibuprofen) reduces gastric damage and improves analgesic and antiinflammatory effects in rodents 68
Determination of Ibuprofen in human plasma by high performance liquid chromatography: validation and application in pharmacokinetic study 65
Mesalamine does not impact on thiopurine-methyl-transferase (TPMT) activity in inflammatory bowel disease (IBD) patients 64
CYP3A and MDR1 (P-glycoprotein) gene expression levels along the human gastrointestinal tract 63
[Ambulatory digital manometry] 62
Lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: Development and influence on insulin stability 62
Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. 62
Phenotype and genotype between italian children and adults for thiopurine methyltransferase 62
Effects of erythromycin on gastrointestinal tract motility. 60
Long-term analgesic effect of clodronate in rodents 60
Pharmacokinetics of disodium clodronate after single intravenous or intramuscolar injection in healthy volunteers 60
Pudendal neuropathy in diabetic patients with faecal incontinence. 60
Genotype and phenotype analysis of thiopurine-methyl-transferase (TPMT) in a northern Italian population 59
Dexibuprofen (S+-isomer ibuprofen) reduces gastric damage and improves analgesic and antiinflammatory effects in rodents. 58
Novel functionalized beta cyclodextrin nanosponge based stable formulation of camptothecin and in vitro cytotoxicity evaluation 56
High Energy Shock Waves (HESW) Increase Paclitaxel Efficacy in a Syngeneic Model of Breast Cancer 55
CYP3A and MDR1 (P-glycoprotein) gene expression levels along the human gastrointestinal tract 54
Paclitaxel incorporato in nanoparticelle lipidiche solide: studio preliminare farmacocinetico e distribuzione cerebrale 54
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. 52
[The lower esophageal sphincter in gastrectomized patients. Manometric study] 51
Ophthalmic delivery of dexamethsone and tobramycin incorporated in solid lipid nanoparticles 51
Expression of the Met/HGF receptor in normal and neoplastic human tissues 51
Nanosponges as innovative glutathione-responsive nanocarrier for doxorubicin delivery 51
In vitro effects of anti-inflammatory drugs incorporated in Solid Lipid Nanoparticles on human peripheral mononuclear blood cells from IBD patients 50
Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity 50
Solid lipid nanoparticles: could they help to improve the efficacy of pharmacologic treatments for brain tumors? 49
Totale 9.634
Categoria #
all - tutte 30.696
article - articoli 0
book - libri 0
conference - conferenze 12.655
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.351


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020892 0 0 0 0 0 157 169 91 188 138 79 70
2020/2021971 130 64 72 46 55 41 93 35 134 106 65 130
2021/20221.212 36 50 20 70 51 32 84 58 35 119 329 328
2022/20231.813 221 150 71 179 136 487 159 100 176 55 57 22
2023/2024738 106 138 63 27 65 133 20 24 8 19 40 95
2024/20251.091 28 98 58 204 593 110 0 0 0 0 0 0
Totale 10.549